tiprankstipranks
Trending News
More News >
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
US Market

Ionis Pharmaceuticals (IONS) Income Statement

Compare
1,464 Followers

Ionis Pharmaceuticals Income Statement

Last quarter (Q3 2025), Ionis Pharmaceuticals's total revenue was $156.72M, an increase of 17.12% from the same quarter last year. In Q3, Ionis Pharmaceuticals's net income was $-128.61M. See Ionis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 705.14M$ 787.65M$ 587.37M$ 810.46M$ 729.26M
Gross Profit
$ 693.92M$ 778.51M$ 573.25M$ 799.61M$ 717.32M
Operating Expenses
$ 1.17B$ 1.13B$ 983.44M$ 829.80M$ 889.40M
Depreciation and Amortization
$ 21.99M$ 22.50M$ 22.11M$ 19.56M$ 17.16M
EBITDA
$ -353.72M$ -235.87M$ -227.76M$ -5.19M$ -111.19M
Operating Income
$ -475.08M$ -353.73M$ -410.19M$ -30.19M$ -172.08M
Other Income/Expenses
$ 15.01M$ 19.77M$ 152.21M$ 1.04M$ 37.53M
Pretax Income
$ -460.07M$ -333.96M$ -257.99M$ -29.15M$ -134.55M
Net Income
$ -453.90M$ -366.29M$ -269.72M$ -28.60M$ -444.26M
Per Share Metrics
Basic EPS
$ -3.04$ -2.56$ -1.90$ -0.20$ -3.18
Diluted EPS
$ -3.04$ -2.56$ -1.90$ -0.20$ -3.18
Weighted Average Shares Outstanding
149.51M 143.00M 141.85M 141.02M 139.61M
Weighted Average Shares Outstanding (Diluted)
149.51M 143.19M 141.85M 141.02M 139.61M
Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History